Chlamydia pneumoniae and Atherosclerosis following Carotid Endarterectomy

Background: Seroepidemiological studies have shown an association between raised antibody titres against Chlamydia pneumoniae, and carotid atherosclerosis or stroke. However, direct evidence for a causal link between arterial infection with C. pneumoniae and carotid disease remains weak. We hypothesized that long-term follow-up of patients with pathologically-proven arterial C. pneumoniae infection might provide further insight into the role of C. pneumoniae in carotid atherosclerosis. Methods: We followed a cohort of 70 carotid endarterectomy patients for ipsilateral restenosis, contralateral progression, and all-cause mortality (four year median follow-up period). All patients had presence or absence of C. pneumoniae in their carotid plaques documented by immunohistochemistry after endarterectomy. A survival function was generated and the log-rank test was used to assess the difference in survival between subjects with and without documented chlamydial infection in their plaque. Results: Baseline demographic and cardiovascular risk factors were similar between the two groups, and survival analysis demonstrated no difference (p>0.05) in all-cause mortality, or all-cause mortality combined with restenosis and progression. Conclusion: Our data finds no causal role for C. pneumoniae in restenosis or progression of carotid disease or mortality in this patient population with advanced carotid atherosclerosis.

[1]  J. Falck,et al.  14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. , 2002, American journal of physiology. Heart and circulatory physiology.

[2]  R. Peeling,et al.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  T. DeGraba,et al.  Presence of Chlamydia pneumoniae in Human Symptomatic and Asymptomatic Carotid Atherosclerotic Plaque , 2001, Stroke.

[4]  P. Roholl,et al.  Distribution of Chlamydia pneumoniae in the Human Arterial System and Its Relation to the Local Amount of Atherosclerosis Within the Individual , 2001, Circulation.

[5]  B. Conrad,et al.  Enhanced Progression of Early Carotid Atherosclerosis Is Related to Chlamydia pneumoniae (Taiwan Acute Respiratory) Seropositivity , 2001, Circulation.

[6]  I. Konishi,et al.  An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis. , 2001, Internal medicine.

[7]  M. G. Cusi,et al.  Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. , 2001, Journal of medical microbiology.

[8]  Werner Poewe,et al.  Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results From a Large Population Study , 2001, Circulation.

[9]  G. Stanek,et al.  Multicenter Comparison Trial of DNA Extraction Methods and PCR Assays for Detection of Chlamydia pneumoniae in Endarterectomy Specimens , 2001, Journal of Clinical Microbiology.

[10]  B. Horne,et al.  Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death , 2001, Circulation.

[11]  P. Roholl,et al.  Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions , 2000, Journal of clinical pathology.

[12]  A. Davies,et al.  Chlamydia pneumoniae Does Not Influence Atherosclerotic Plaque Behavior in Patients With Established Carotid Artery Stenosis , 2000, Stroke.

[13]  A. Busjahn,et al.  Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. , 2000, The Journal of laboratory and clinical medicine.

[14]  C. Zoccali,et al.  Inflammation is associated with carotid atherosclerosis in dialysis patients , 2000, Journal of hypertension.

[15]  S. Blankenberg,et al.  Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? , 2000, Stroke.

[16]  R. Sacco,et al.  Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. , 2000, Stroke.

[17]  B. Fagerberg,et al.  Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness. , 2000, Stroke.

[18]  P. Apfalter,et al.  Isolation and Continuous Growth of Chlamydia pneumoniae from Arterectomy Specimens , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[19]  A. Plant,et al.  Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. , 1999, The American journal of cardiology.

[20]  L. Weinehall,et al.  Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. , 1999, Stroke.

[21]  H. Steinmetz,et al.  Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. , 1999, Circulation.

[22]  F. Blasi,et al.  Demonstration of Viable Chlamydia pneumoniae in Atherosclerotic Plaques of Carotid Arteries by Reverse Transcriptase Polymerase Chain Reaction , 1999, Annals of vascular surgery.

[23]  B. Horne,et al.  Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. , 1999, Circulation.

[24]  P. Apfalter,et al.  Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction. , 1999, Wiener klinische Wochenschrift.

[25]  B. Fagerberg,et al.  Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. , 1999, Stroke.

[26]  K. Dalhoff,et al.  Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. , 1998, Atherosclerosis.

[27]  W. Solbach,et al.  Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients , 1998, Medical Microbiology and Immunology.

[28]  M. Shirai,et al.  Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery. , 1998, Stroke.

[29]  G. Lip,et al.  Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. , 1998, Stroke.

[30]  D. Paterson,et al.  Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients , 1998, Pathology.

[31]  W. F. Jackson,et al.  Characterization and function of Ca 2 1-activated K 1 channels in arteriolar muscle cells , 1997 .

[32]  J Kievit,et al.  Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. , 1998, Stroke.

[33]  A. Camm,et al.  Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. , 1998, Circulation.

[34]  I. Fong,et al.  Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.

[35]  K. Burnand,et al.  Recurrent carotid stenosis after carotid endarterectomy , 1997, The British journal of surgery.

[36]  E. Gurfinkel,et al.  Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.

[37]  M. Maass,et al.  Endovascular Presence of Chlamydia pneumoniae in Patients with Hemodynamically Effective Carotid Artery Stenosis , 1997, Angiology.

[38]  A. Lee,et al.  Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. , 1997, The Journal of infectious diseases.

[39]  R. Schmidt,et al.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. , 1997, The American journal of pathology.

[40]  P. Saikku,et al.  Association of chlamydial infection with cerebrovascular disease. , 1996, Stroke.

[41]  A. Coulson,et al.  Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. , 1995, Circulation.

[42]  A. Folsom,et al.  Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.

[43]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[44]  D. Strandness,et al.  Carotid artery duplex scanning , 1987, Journal of clinical ultrasound : JCU.